Results 1 to 10 of about 8,269 (200)
Unveiling relative lymphopenia and elevated monocyte‐to‐lymphocyte count as novel independent adverse prognostic factors in chronic myelomonocytic leukemia (CMML)—Proposal of the objective prognostic index for CMML (OPIC) [PDF]
Chronic myelomonocytic leukemia (CMML) shows marked prognostic heterogeneity. Although leukocytosis is a recognized adverse prognostic factor, the contribution of its individual components remains insufficiently defined.
Xavier Calvo +19 more
doaj +3 more sources
Assessment of the IPSS-M in chronic myelomonocytic leukemia [PDF]
: Prognostication in chronic myelomonocytic leukemia (CMML) remains a challenge because of the biological complexity and variable clinical course of the disease.
Laura Palomo +35 more
doaj +2 more sources
Hypomethylating drugs are useful and approved in the management of myelodysplastic syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML). However, phase 2 and 3 studies that assessed these agents in MDS, have included only a small number of CMML ...
Elena Elli +4 more
doaj +4 more sources
ADGRE2: A Promising Immunotherapeutic Target in Acute Myeloid Leukemia and Chronic Myelomonocytic Leukemia [PDF]
ABSTRACT Acute myeloid leukemia (AML) and chronic myelomonocytic leukemia (CMML) are heterogeneous myeloid malignancies with limited therapeutic options and often poor long‐term prognosis due to persistence of therapy‐resistant leukemic stem cells (LSC).
Neiss J +9 more
europepmc +2 more sources
CD69 blockade restores the bone marrow niche and delays leukemogenesis in a mouse model of Nras G12D-driven chronic myelomonocytic leukemia [PDF]
Background A subset of patients with chronic myelomonocytic leukemia (CMML) carries NRAS mutations, which are associated with shorter overall survival and an increased risk of transformation to acute myeloid leukemia.
Yuchen Li +11 more
doaj +2 more sources
Chronic Myelomonocytic Leukemia: Hematopathology Perspective [PDF]
Our understanding of chronic myelomonocytic leukemia (CMML) has evolved tremendously over the past decade. Large-scale sequencing studies have led to increased insight into the genomic landscape of CMML and clinical implications of these changes. This in
Siba El Hussein +4 more
doaj +1 more source
Myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML) are associated with systemic inflammatory or autoimmune diseases in 10-20 % of cases. Among them, immune thrombocytopenia (ITP) has been reported but large studies assessing this
Vincent Jachiet +27 more
doaj +1 more source
Introduction: Chronic myelomonocytic leukemia (CMML) is a hematologic disorder that is an overlap syndrome between myelodysplastic syndromes and myeloproliferative neoplasms, and can be associated with autoimmune and inflammatory diseases.
Marie-Camille Lafargue +41 more
doaj +1 more source
How I diagnose and treat chronic myelomonocytic leukemia
Chronic myelomonocytic leukemia (CMML) is a myelodysplastic syndrome/myeloproliferative overlap neoplasm characterized by sustained peripheral blood monocytosis and an inherent risk for transformation to acute myeloid leukemia (15-30% over 3-5 years ...
Mrinal M. Patnaik
doaj +1 more source
Chronic Myelomonocytic Leukemia Gold Jubilee
Chronic myelomonocytic leukemia (CMML) was named 50 years ago to describe a myeloid malignancy whose onset is typically insidious. This disease is now classified by the World Health Organisation as a myelodysplastic syndrome (MDS)-myeloproliferative ...
Eric Solary, Raphael Itzykson
doaj +1 more source

